Waltham, Massachusetts

Boston Properties Marks Groundbreaking of 180 CityPoint

Retrieved on: 
Thursday, July 29, 2021
Science, Commercial Building & Real Estate, Other Science, Construction & Property, Biotechnology, Pharmaceutical, Health, REIT, Counties of England, Citypoint, City Point, Waltham, Massachusetts, London, Waltham station, BXP, City of London, Waltham, Boston Properties, Geography of England, BXP Life Sciences, Boston Properties, BXP LIFE SCIENCES, BOSTON PROPERTIES

On Friday, July 16, 2021 Boston Properties, Inc. (NYSE:BXP), the largest publicly traded developer, owner, and manager of Class A office properties in the United States, celebrated the groundbreaking of 180 CityPoint, a 329,000 square foot life sciences building currently under construction at 180 Third Avenue in Waltham, Massachusetts.

Key Points: 
  • On Friday, July 16, 2021 Boston Properties, Inc. (NYSE:BXP), the largest publicly traded developer, owner, and manager of Class A office properties in the United States, celebrated the groundbreaking of 180 CityPoint, a 329,000 square foot life sciences building currently under construction at 180 Third Avenue in Waltham, Massachusetts.
  • 180 CityPoint is located within the CityPoint district in Waltham, a highly desirable location for leading and emerging companies in the life sciences and biotechnology sector.
  • The construction of 180 CityPoint builds on BXPs 4.9 million square feet of lab and Class A office properties in the Waltham/Lexington region of Massachusetts.
  • Boston Properties will own and operate 180 CityPoint.

Blue Cross Blue Shield of Massachusetts Partners with Equity Now & Beyond to Provide Vaccine Clinics and Outreach to Local Immigrant Communities

Retrieved on: 
Friday, July 23, 2021
Regions of the United States, Geography of the United States, Geography of Massachusetts, Medical research, Dorchester, Boston, Mattapan, COVID-19 vaccine, Waltham, Massachusetts, Vaccine, Massachusetts, Vaccination, Boston

BOSTON, July 23, 2021 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") today announced a partnership with Equity Now & Beyond, a collaborative of five immigrant-led organizations, to host vaccine clinics and provide educational outreach in immigrant communities across Massachusetts.

Key Points: 
  • BOSTON, July 23, 2021 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") today announced a partnership with Equity Now & Beyond, a collaborative of five immigrant-led organizations, to host vaccine clinics and provide educational outreach in immigrant communities across Massachusetts.
  • Recent Massachusetts Department of Health data show significant gaps in vaccination rates among Black and Latino residents compared to White and Asian residents.
  • With financial support from Blue Cross, Equity Now & Beyond is hosting more than 20 vaccine clinics at local churches, schools and community centers across the state including Mattapan, Dorchester, Lynn, Brighton, Waltham, Brockton and Worcester.
  • We are proud to support the grassroots efforts of Equity Now & Beyond to help promote the COVID-19 vaccines and support Massachusetts's immigrant communities."

Massachusetts eHealth Collaborative Fulfills Mission; Completes Final Dissolution

Retrieved on: 
Tuesday, July 20, 2021
Health informatics, Waltham, Massachusetts, EHR, Health data, Electronic health records

WALTHAM, Mass., July 20, 2021 /PRNewswire-PRWeb/ -- The Massachusetts eHealth Collaborative (MAeHC), a national leader in health information technology for over 15 years, has been dissolved after distributing its remaining assets to six local public charities.

Key Points: 
  • WALTHAM, Mass., July 20, 2021 /PRNewswire-PRWeb/ -- The Massachusetts eHealth Collaborative (MAeHC), a national leader in health information technology for over 15 years, has been dissolved after distributing its remaining assets to six local public charities.
  • "Now, with our work completed, and our mission fulfilled, it's time to pass the torch to a new generation of HIT innovators."
  • Finally, in order to identify Massachusetts public charities to receive its remaining assets, the MAeHC Board formed a Grant Program Selection Subcommittee to conduct an RFP process.
  • Massachusetts Health Data Consortium will design, test, and complete a documented prototype for Electronic Prior Authorization integrated with the EHR.

Raytheon Technologies Appoints Jeff Shockey as Senior Vice President of Global Government Relations

Retrieved on: 
Friday, July 16, 2021
Companies, Economy of the United States, Raytheon Company, Raytheon Technologies, Science and technology in the United States, Jeff Shockey, Waltham, Massachusetts, Arms industry

WALTHAM, Mass., July 16, 2021 /PRNewswire/ --Jeff Shockey will join Raytheon Technologies (NYSE: RTX) as senior vice president of Global Government Relations, succeeding Timothy McBride, who plans to leave the company later this year.

Key Points: 
  • WALTHAM, Mass., July 16, 2021 /PRNewswire/ --Jeff Shockey will join Raytheon Technologies (NYSE: RTX) as senior vice president of Global Government Relations, succeeding Timothy McBride, who plans to leave the company later this year.
  • "With a career in government and the private sector, Jeff will leverage his commercial and defense and industry relationships to drive government relations as a key enabler of our business."
  • Shockey joins Raytheon Technologies from Boeing, where he served as vice president, Federal Affairs and International Policy for Government Operations; and most recently as vice president, Global Sales and Marketing for Defense, Space & Security and Global Services' Government Services portfolio.
  • Raytheon Technologies Corporation is an aerospace and defense company that provides advanced systems and services for commercial, military and government customers worldwide.

AdDaptive Intelligence Releases Site Analytics Product to Show Lift from Ad Campaigns among Target Accounts

Retrieved on: 
Thursday, July 15, 2021
Articles, Business intelligence, Analytics, Big data, Web analytics, Data, Economy, Audience measurement, Google Analytics

"Site Analytics builds upon our focus on B2B analytics by adding insight into on-site activity as it pertains to ad campaigns," said Kevin O'Malley, CEO and co-founder.

Key Points: 
  • "Site Analytics builds upon our focus on B2B analytics by adding insight into on-site activity as it pertains to ad campaigns," said Kevin O'Malley, CEO and co-founder.
  • In other words, Site Analytics doesn't just show the difference an ad campaign makes in terms of site traffic it arms advertisers with valuable knowledge about their key accounts.
  • Site Analytics is now part of AdDaptive's standard reporting suite offered to customers: Under the Account Insight Reporting (AIR) umbrella, customers now receive Campaign Analytics and Site Analytics reports.
  • AdDaptive's proprietary technology bridges offline and online data, optimizes ad campaigns, and provides transparent B2B analytics to help clients reach the accounts that matter most.

Thermo Fisher Scientific Opens cGMP Plasmid DNA Manufacturing Facility in Carlsbad, California

Retrieved on: 
Thursday, July 15, 2021
Companies, Thermo Fisher Scientific, Virology, Patheon, Industry economics), Thermo, Vaccine, Fisher Scientific, Mergers and acquisitions, Fermentas

WALTHAM, Mass., July 15, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.

Key Points: 
  • WALTHAM, Mass., July 15, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.
  • "Demand for commercial plasmid DNA is outpacing supply as the development of transformative gene therapies and vaccines accelerates globally," said Marc N. Casper, chairman, president and chief executive officer, Thermo Fisher Scientific.
  • To celebrate the opening of the new facility, Thermo Fisher hosted a ribbon-cutting ceremony today with local government officials including U.S.
  • To learn more about Thermo Fisher's new cGMP Plasmid DNA manufacturing facility, please visit www.thermofisher.com/patheon .

Tecogen Schedules Earnings Release and Conference Call for Second Quarter 2021 Results

Retrieved on: 
Tuesday, July 13, 2021
Corporate finance, Stock market, Earnings call, Teleconferencing, Lluís Companys, Waltham, Massachusetts, Conference call, Articles, Economy, Spanish politicians

WALTHAM, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tecogen Inc. (OTCQX: TGEN), will release financial results for the second quarter of 2021 on Thursday, August 12, 2021.

Key Points: 
  • WALTHAM, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tecogen Inc. (OTCQX: TGEN), will release financial results for the second quarter of 2021 on Thursday, August 12, 2021.
  • The earnings press release and supplemental earnings call slides will be available on the Companys website at www.Tecogen.com in the Investor Relations section under Financial Results .
  • Members of Tecogens senior management will hold a conference call and webcast on the same day at 11:00 AM Eastern Time to discuss the companys second quarter 2021 financial performance.
  • Participants should ask to be joined to theTecogen Second Quarter 2021 earnings call.

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 28, 2021

Retrieved on: 
Wednesday, July 7, 2021
Companies, Mergers and acquisitions, Industry economics), Thermo Fisher Scientific, Applied Biosystems, Invitrogen, Patheon, Thermo, Fisher Scientific, Waltham, Massachusetts, Life Technologies

WALTHAM, Mass., July 7, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that it will release its financial results for the second quarter 2021 before the market opens on Wednesday, July 28, 2021, and will hold a conference call on the same day at 8:30 a.m. EDT.

Key Points: 
  • WALTHAM, Mass., July 7, 2021 /PRNewswire/ --Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science,announced that it will release its financial results for the second quarter 2021 before the market opens on Wednesday, July 28, 2021, and will hold a conference call on the same day at 8:30 a.m. EDT.
  • The earnings press release and related information can be found in that section of our website under "Financial Results."
  • Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion.
  • Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon.

Raytheon Technologies to release second quarter results on July 27, 2021

Retrieved on: 
Tuesday, July 6, 2021
Companies, Economy of the United States, Raytheon Company, Science and technology in the United States, Raytheon Technologies, United Technologies, Waltham, Massachusetts, RTX, Aerospace

WALTHAM, Mass., July 6, 2021 /PRNewswire/ --Raytheon Technologies (NYSE: RTX) will issue its second quarter 2021 earnings on Tuesday, July 27, prior to the stock market opening.

Key Points: 
  • WALTHAM, Mass., July 6, 2021 /PRNewswire/ --Raytheon Technologies (NYSE: RTX) will issue its second quarter 2021 earnings on Tuesday, July 27, prior to the stock market opening.
  • A presentation corresponding with the conference call will be available on the company's website at www.rtx.com for downloading prior to the call.
  • Raytheon Technologies Corporation is an aerospace and defense company that provides advanced systems and services for commercial, military and government customers worldwide.
  • The company, formed in 2020 through the combination of Raytheon Company and the United Technologies Corporation aerospace businesses, is headquartered in Waltham, Massachusetts.

Raytheon Technologies Board of Directors Declares Quarterly Cash Dividend

Retrieved on: 
Monday, June 21, 2021
Companies, Economy of the United States, Raytheon Company, Science and technology in the United States, Raytheon Technologies, Dividend, United Technologies, RTX, Waltham, Massachusetts

WALTHAM, Mass., June 21, 2021 /PRNewswire/ --Raytheon Technologies Corporation (NYSE: RTX) announced today that its board of directors declared a dividend of 51 cents per outstanding share of RTX common stock.

Key Points: 
  • WALTHAM, Mass., June 21, 2021 /PRNewswire/ --Raytheon Technologies Corporation (NYSE: RTX) announced today that its board of directors declared a dividend of 51 cents per outstanding share of RTX common stock.
  • Raytheon Technologies has paid cash dividends on its common stock every year since 1936.
  • Raytheon Technologies Corporation is an aerospace and defense company that provides advanced systems and services for commercial, military and government customers worldwide.
  • The company, formed in 2020 through the combination of Raytheon Company and the United Technologies Corporation aerospace businesses, is headquartered in Waltham, Massachusetts.